Garbe C - Search Results

1

Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells.

Beck D, Niessner H, Smalley KS, Flaherty K, Paraiso KH, Busch C, Sinnberg T, Vasseur S, Iovanna JL, Drießen S, Stork B, Wesselborg S, Schaller M, Biedermann T, Bauer J, Lasithiotakis K, Weide B, Eberle J, Schittek B, Schadendorf D, Garbe C, Kulms D, Meier F. Beck D, et al. Among authors: garbe c. Sci Signal. 2013 Jan 29;6(260):ra7. doi: 10.1126/scisignal.2003057. Sci Signal. 2013. PMID: 23362240 Free PMC article. Clinical Trial.

2

Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin.

Murakami M, Ohtake T, Dorschner RA, Schittek B, Garbe C, Gallo RL. Murakami M, et al. Among authors: garbe c. J Invest Dermatol. 2002 Nov;119(5):1090-5. doi: 10.1046/j.1523-1747.2002.19507.x. J Invest Dermatol. 2002. PMID: 12445197 Free article.

3

Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children.

Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C. Wiecker TS, et al. Among authors: garbe c. Cancer. 2003 Feb 1;97(3):628-38. doi: 10.1002/cncr.11114. Cancer. 2003. PMID: 12548604 Free article.

4

Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.

Garbe C, Paul A, Kohler-Späth H, Ellwanger U, Stroebel W, Schwarz M, Schlagenhauff B, Meier F, Schittek B, Blaheta HJ, Blum A, Rassner G. Garbe C, et al. J Clin Oncol. 2003 Feb 1;21(3):520-9. doi: 10.1200/JCO.2003.01.091. J Clin Oncol. 2003. PMID: 12560444

5

Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.

Garbe C, Leiter U, Ellwanger U, Blaheta HJ, Meier F, Rassner G, Schittek B. Garbe C, et al. Cancer. 2003 Apr 1;97(7):1737-45. doi: 10.1002/cncr.11250. Cancer. 2003. PMID: 12655531 Free article.

6

Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data.

Bauer J, Garbe C. Bauer J, et al. Among authors: garbe c. Pigment Cell Res. 2003 Jun;16(3):297-306. doi: 10.1034/j.1600-0749.2003.00047.x. Pigment Cell Res. 2003. PMID: 12753404 Review.

7

Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promotes progression of melanocytes to melanoma.

Meier F, Caroli U, Satyamoorthy K, Schittek B, Bauer J, Berking C, Möller H, Maczey E, Rassner G, Herlyn M, Garbe C. Meier F, et al. Among authors: garbe c. Exp Dermatol. 2003 Jun;12(3):296-306. doi: 10.1034/j.1600-0625.2003.120310.x. Exp Dermatol. 2003. PMID: 12823444

8

Risk estimation for malignant transformation of melanocytic nevi.

Bauer J, Garbe C. Bauer J, et al. Among authors: garbe c. Arch Dermatol. 2004 Jan;140(1):127; author reply 127. doi: 10.1001/archderm.140.1.127-a. Arch Dermatol. 2004. PMID: 14732675 No abstract available.

9

The natural course of cutaneous melanoma.

Leiter U, Meier F, Schittek B, Garbe C. Leiter U, et al. Among authors: garbe c. J Surg Oncol. 2004 Jul 1;86(4):172-8. doi: 10.1002/jso.20079. J Surg Oncol. 2004. PMID: 15221923 Review.

10

Risk factors of incident melanocytic nevi: a longitudinal study in a cohort of 1,232 young German children.

Bauer J, Büttner P, Wiecker TS, Luther H, Garbe C. Bauer J, et al. Among authors: garbe c. Int J Cancer. 2005 May 20;115(1):121-6. doi: 10.1002/ijc.20812. Int J Cancer. 2005. PMID: 15645451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

795 results

Search Page

Filters